Cabozantinib

Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl, and Flt3 (IC50s: 0.035, 1.3, 4.6, 7 and 11.3 nM).

Price Not Available 50 mg Cabozantinib Supplier Page

Catalog Number	T2586
Alternative Name(s)	XL184 , BMS-907351
Research Area	Tyrosine Kinase/Adaptors\|\|\|Apoptosis\|\|\|Angiogenesis
Molecular Formula	C28H24FN3O5
CAS#	849217-68-1
Purity	99.59%
SMILES	COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC
Size	50 mg
Supplier Page	https://www.targetmol.com/compound/Cabozantinib
Additional Information	https://www.targetmol.com/datasheet/T2586